Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line (DOMENICA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05201547 |
|
Recruitment Status :
Recruiting
First Posted : January 21, 2022
Last Update Posted : February 29, 2024
|
Sponsor:
ARCAGY/ GINECO GROUP
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 2026 |
| Estimated Study Completion Date : | October 2029 |